Get the Stockscreener App
0.701
4.91%
0.0328
Nautilus Biotechnology Inc stock is traded at $0.701, with a volume of 163.42K.
It is up +4.91% in the last 24 hours and down -4.63% over the past month.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
See More
Previous Close:
$0.6682
Open:
$0.665
24h Volume:
163.42K
Relative Volume:
0.56
Market Cap:
$88.54M
Revenue:
-
Net Income/Loss:
$-70.78M
P/E Ratio:
-1.2518
EPS:
-0.56
Net Cash Flow:
$-61.27M
1W Performance:
-1.63%
1M Performance:
-4.63%
6M Performance:
-54.48%
1Y Performance:
-70.79%
1-Day Range:
$0.66
$0.713
1-Week Range:
$0.66
$0.72
52-Week Range:
$0.66
$3.09
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Name
Nautilus Biotechnology Inc
Sector
Industry
Phone
206-333-2001
Address
2701 EASTLAKE AVE EAST, SEATTLE
Compare NAUT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
0.701 | 88.41M | 0 | -70.78M | -61.27M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-24 | Downgrade | Goldman | Neutral → Sell |
| Jun-27-24 | Initiated | Guggenheim | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-06-22 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-02-21 | Initiated | Cowen | Outperform |
| Aug-04-21 | Initiated | Goldman | Neutral |
| Jul-13-21 | Initiated | Jefferies | Buy |
View All
Nautilus Biotechnology Inc Stock (NAUT) Latest News
Combining price and volume data for Nautilus Biotechnology Inc.July 2025 PreEarnings & Weekly High Momentum Picks - Newser
Published on: 2025-08-20 02:35:17 - Newser
Order flow analysis tools used on Nautilus Biotechnology Inc.Weekly Investment Recap & High Accuracy Trade Signal Alerts - Newser
Is Nautilus Biotechnology Inc. stock poised for growth2025 Trading Recap & Daily Profit Maximizing Tips - Newser
Using R and stats models for Nautilus Biotechnology Inc. forecastingInsider Selling & Community Consensus Trade Alerts - Newser
Nautilus Biotechnology Inc. stock retracement – recovery analysisMarket Growth Summary & AI Driven Stock Movement Reports - Newser
Nautilus Biotechnology Inc. stock momentum explainedTrade Signal Summary & Daily Profit Focused Stock Screening - Newser
Why Nautilus Biotechnology Inc. stock attracts strong analyst attentionJuly 2025 Institutional & Risk Controlled Daily Plans - Newser
Detecting support and resistance levels for Nautilus Biotechnology Inc.2025 Price Targets & Weekly High Return Opportunities - Newser
Can trapped investors hope for a rebound in Nautilus Biotechnology Inc.Weekly Trade Recap & Verified Swing Trading Watchlists - Newser
Using Python tools to backtest Nautilus Biotechnology Inc. strategies2025 Stock Rankings & Daily Momentum Trading Reports - Newser
Tools to monitor Nautilus Biotechnology Inc. recovery probabilityPortfolio Gains Summary & Safe Capital Growth Trade Ideas - Newser
Can swing trading help recover from Nautilus Biotechnology Inc. lossesJuly 2025 Decliners & Reliable Volume Spike Trade Alerts - Newser
How to integrate Nautilus Biotechnology Inc. into portfolio analysis toolsGap Up & Weekly Setup with High ROI Potential - Newser
XTX Topco Ltd Invests $31,000 in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
What makes Nautilus Biotechnology Inc. stock price move sharplyQuarterly Risk Review & Free Weekly Watchlist of Top Performers - Newser
Using data filters to optimize entry into Nautilus Biotechnology Inc.July 2025 Price Swings & Advanced Technical Analysis Signals - Newser
Building trade automation scripts for Nautilus Biotechnology Inc.2025 Valuation Update & Reliable Momentum Entry Alerts - Newser
Visual trend scoring systems applied to Nautilus Biotechnology Inc.Weekly Profit Analysis & Technical Confirmation Alerts - Newser
Quantitative breakdown of Nautilus Biotechnology Inc. recent moveWeekly Trading Summary & Community Driven Trade Alerts - Newser
Will Nautilus Biotechnology Inc. stock go up soonAnalyst Upgrade & Smart Allocation Stock Tips - Newser
Nautilus Biotechnology Inc. Consolidation Zone May Signal AccumulationJuly 2025 Levels & High Win Rate Trade Tips - beatles.ru
What Fibonacci levels say about Nautilus Biotechnology Inc. reboundWeekly Investment Recap & Advanced Technical Signal Analysis - Newser
Heatmap analysis for Nautilus Biotechnology Inc. and competitorsTrade Volume Report & Fast Momentum Stock Entry Tips - Newser
Nautilus Biotechnology Inc. At Decision Level — Rebound or ResistancePortfolio Value Summary & Daily Profit Maximizing Tips - beatles.ru
Nautilus Biotechnology Inc Stock (NAUT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Nautilus Biotechnology Inc Stock (NAUT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Mallick Parag | Chief Scientist |
May 08 '25 |
Buy |
0.73 |
12,000 |
8,788 |
20,491,892 |
| Mallick Parag | Chief Scientist |
May 12 '25 |
Buy |
0.73 |
1,500 |
1,098 |
20,493,392 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 19 '25 |
Buy |
0.99 |
53,300 |
53,028 |
10,117,788 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 20 '25 |
Buy |
1.00 |
23,933 |
23,890 |
10,141,721 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):